| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| idelalisib | phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | small molecule | NA | drugbank , DGIDB | Chronic Lymphocytic Leukemia[MeSHID:D015451] Relapse[MeSHID:D012008] Neoplasm Metastasis[MeSHID:D009362] B-Cell Lymphomas[MeSHID:D016393] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.86 | approved | inhibitor |
| idelalisib | pi3-kinase delta | NA | Successful target | TTD , DGIDB | Chronic Lymphocytic Leukemia[MeSHID:D015451] Relapse[MeSHID:D012008] Neoplasm Metastasis[MeSHID:D009362] B-Cell Lymphomas[MeSHID:D016393] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.86 | approved | inhibitor |
| idelalisib | pi3-kinase delta | NA | Successful target | TTD , DGIDB | Chronic Lymphocytic Leukemia[MeSHID:D015451] Relapse[MeSHID:D012008] Neoplasm Metastasis[MeSHID:D009362] B-Cell Lymphomas[MeSHID:D016393] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.86 | approved | unknown |
| click here to return to the previous page | ||||||||